Centessa Pharmaceuticals plc (LON:0ACX)
15.26
+0.30 (2.04%)
At close: Jul 16, 2025
Centessa Pharmaceuticals Revenue
Centessa Pharmaceuticals had revenue of $15.00M USD in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $15.00M, up 118.88% year-over-year.
Revenue (ttm)
$15.00M
Revenue Growth
+118.88%
P/S Ratio
133.85
Revenue / Employee
$194.81K
Employees
77
Market Cap
1.55B GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
Centessa Pharmaceuticals News
- 13 days ago - Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa's Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist - GlobeNewsWire
- 4 weeks ago - Centessa gets clearance to begin trial of ORX142 - Seeking Alpha
- 4 weeks ago - Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year - GlobeNewsWire
- 2 months ago - Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025 - GlobeNewsWire
- 2 months ago - This Centessa Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday - Benzinga
- 3 months ago - Centessa Pharmaceuticals: Smooth Move To New Programs, But Questions Remain - Seeking Alpha
- 4 months ago - Decoding Centessa Pharmaceuticals PLC (CNTA): A Strategic SWOT Insight - GuruFocus